v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities    
Net income $ 137.0 $ 117.0
Adjustments to reconcile net income to net cash flows provided by (used in) operating activities:    
Depreciation, amortization and accretion 23.0 18.0
Provision for credit losses 18.5 17.5
Deferred tax expense (benefit) 7.0 10.0
Loans originated for sale (396.0) (328.0)
Loans sold 395.0 353.0
Net (gains) losses on sale of loans (8.0) (4.0)
Net change in:    
Interest receivable (1.0) (2.0)
Interest payable 5.0 (3.0)
Bank owned life insurance, excluding purchases (4.0) (2.0)
Other, net (25.0) (112.0)
Net cash flows provided by (used in) operating activities 151.0 64.0
Investing Activities    
Net change in loans and leases, excluding sales and transfers (339.0) (300.0)
Debt securities available for sale:    
Purchases (282.0) (118.0)
Maturities/payments 213.0 152.0
Debt securities held to maturity:    
Purchases (142.0) (126.0)
Maturities/payments 78.0 78.0
Increase in premises and equipment (18.0) (21.0)
Net proceeds from sales of portfolio loans 191.0 0.0
Net cash flows provided by (used in) investing activities (299.0) (335.0)
Financing Activities    
Deposits 142.0 132.0
Short-term borrowings 139.0 712.0
Proceeds from issuance of long-term borrowings 105.0 6.0
Repayment of long-term borrowings (5.0) (504.0)
Repurchases of common stock (35.0) (10.0)
Cash dividends paid on common stock (43.0) (44.0)
Other, net 6.0 5.0
Net cash flows provided by (used in) financing activities 309.0 297.0
Net Increase (Decrease) in Cash and Cash Equivalents 161.0 26.0
Cash and cash equivalents at beginning of period 2,498.0 2,419.0
Cash and Cash Equivalents at End of Period $ 2,659.0 $ 2,445.0